MARKET

HSCS

HSCS

Heart Test Laboratories, Inc.
NASDAQ
0.1171
-0.0028
-2.34%
After Hours: 0.1167 -0.0004 -0.34% 17:16 03/27 EDT
OPEN
0.1179
PREV CLOSE
0.1199
HIGH
0.1200
LOW
0.1160
VOLUME
819.23K
TURNOVER
0
52 WEEK HIGH
1.490
52 WEEK LOW
0.1106
MARKET CAP
7.68M
P/E (TTM)
-0.2384
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at HSCS last week (0318-0322)?
Weekly Report · 2d ago
Weekly Report: what happened at HSCS last week (0311-0315)?
Weekly Report · 03/18 12:17
HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024
Heart Test Laboratories reported earnings per share of -3 cents. The company reported revenue of $14,700. This was above the analyst estimate for EPS of -6 cents. Heart Test Laboratories was down 2% after the market closed on Wednesday.   
Investorplace · 03/15 01:54
Recap: Heart Test Laboratories Q3 Earnings
Heart Test Laboratories reported its Q3 earnings on March 14. Heart Test Laboratories beat estimates by 50.0%. The company's revenue was up $12 thousand from the same period last year. The company is expected to report its earnings on Thursday, March 14 at 4:00pm.
Benzinga · 03/14 21:45
Heart Test Laboratories reports Q3 results
Seeking Alpha · 03/14 21:16
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Heart Test Laboratories, Inc. Reports financial results for the third quarter fiscal 2024 ended January 31, 2024. The company is an artificial intelligence-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Heart Test Laboratories reports a business update.
Barchart · 03/14 15:15
HeartSciences' Announces Peer-Reviewed Publication Evaluating Use Of MyoVista Technology To Detect Asymptomatic Left Ventricular Dysfunction In Patients With Type 2 Diabetes
Heart Test Laboratories, Inc. Announces publication in Cardiovascular Diabetology of an independent, peer-reviewed study utilizing its MyoVista proprietary technology. The study evaluated the accuracy of an AI-ECG model in screening for heart failure in type 2 diabetes patients. HeartSciences is a company focused on transforming ECGs/EKGs to save lives.
Benzinga · 03/12 13:07
Weekly Report: what happened at HSCS last week (0304-0308)?
Weekly Report · 03/11 12:11
More
About HSCS
Heart Test Laboratories, Inc., doing business as HeartSciences, is an artificial intelligence electrocardiogram (AI ECG) company. The Company is focused on using AI to transform ECG to save lives through earlier detection of heart disease. The Company’s initial focus is on applying technology to extend the clinical indications for use of an electrocardiograph (ECG) device. Its first device, the MyoVista is an ECG that can be used in a range of clinical settings and provides diagnostic information to a qualified healthcare professional on cardiac dysfunction which has traditionally only been provided using cardiac imaging. In addition, MyoVista provides conventional ECG information. The Company focuses on marketing its device both domestically and internationally to various hospitals, clinics, and medical centers and manufacturing the devices using outsourced production facilities.

Webull offers Heart Test Laboratories Inc stock information, including NASDAQ: HSCS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSCS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HSCS stock methods without spending real money on the virtual paper trading platform.